Microparticle-Based Ocular Implants is a type of sustained-release ocular drug delivery system that utilizes biodegradable or non-biodegradable microparticles as carriers to deliver therapeutic agents directly to ocular tissues, distinguishing it from conventional implants by its particulate microstructure enabling localized, prolonged, and controlled drug release.
23
Publications
1.1K
Citations
158
Authors
66
Institutions
Publications per year
2017–2026
10
Parents
Publications
23
Patricia Checa-Casalengua, Caihui Jiang, Irene Bravo‐Osuna et al. · Journal of Controlled Release · 2011 · 108 citations
A new model of subretinal neovascularization in the rabbit.
Hideya Kimura, Taiji Sakamoto, David R. Hinton et al. · PubMed · 1995 · 86 citations · Full text
1–5 of 23
Authors
158
- RH
7
h-index
- IB
5
h-index
- MJ
4
h-index
- IT
4
h-index
- RV
2
h-index
1–5 of 158
Institutions
66
Universidad Complutense de Madrid
Madrid, Spain
6 h-index
23 publications
1.3K citations
Harvard University
Cambridge, United States
5 h-index
12 publications
888 citations
Massachusetts Eye and Ear Infirmary
Boston, United States
4 h-index
10 publications
726 citations
Smith-Kettlewell Eye Research Institute
San Francisco, United States
4 h-index
10 publications
726 citations
Instituto de Investigación Sanitaria del Hospital Clínico San Carlos
Madrid, Spain
3 h-index
12 publications
669 citations
Doheny Eye Institute
Los Angeles, United States
3 h-index
7 publications
209 citations
Centro de Retina Médica y Quirúrgica
Zapopan, Mexico
2 h-index
8 publications
164 citations
Zagazig University
Zagazig, Egypt
2 h-index
2 publications
41 citations
1–8 of 66
Venues
- PubMed
Repository · 3 publications · 256 citations
3
h-index
- Pharmaceutics
3 publications · 76 citations
3
h-index
- Journal of Controlled Release
3 publications · 233 citations
3
h-index
- Translational Vision Science & Technology
TVST · 2 publications · 41 citations
2
h-index
- PLoS ONE
2 publications · 30 citations
2
h-index
1–5